Menu
Back to Archived Journals » Gastrointestinal Cancer: Targets and Therapy » Volume 7
Gastric neuroendocrine tumors: management and challenges
Authors Kwon DH, Nakakura EK, Bergsland EK, Dai SC
Received 16 March 2017
Accepted for publication 2 August 2017
Published 29 September 2017 Volume 2017:7 Pages 31—37
DOI https://doi.org/10.2147/GICTT.S109028
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Akshita Wason
Peer reviewer comments 2
Editor who approved publication: Dr Eileen O'Reilly
Daniel H Kwon,1 Eric K Nakakura,2 Emily K Bergsland,3 Sun-Chuan Dai4
1Department of Medicine, 2Division of General Surgery, 3Division of Hematology/Oncology, 4Division of Gastroenterology, University of California San Francisco, San Francisco, CA, USA
Abstract: Gastric neuroendocrine tumors derive from enterochromaffin-like cells in the stomach mucosa. Based on histologic, serologic, and endoscopic findings, they may be further differentiated into types I, II, and III, with varying degrees of aggressiveness. In this article, diagnostic and classification strategies are reviewed, as are endoscopic, systemic, and surgical modalities for management. A multidisciplinary approach is advocated to provide the most effective patient care.
Keywords: neuroendocrine, tumor, carcinoid, gastrin, stomach
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.